Imunon (NASDAQ:IMNN) Stock Price Up 5.6%

Shares of Imunon, Inc. (NASDAQ:IMNN) traded up 5.6% during trading on Tuesday . The stock traded as high as $1.15 and last traded at $1.14. 294,313 shares were traded during mid-day trading, a decline of 74% from the average session volume of 1,151,619 shares. The stock had previously closed at $1.08.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and set a $14.00 target price on shares of Imunon in a research report on Thursday, August 15th.

Imunon Trading Up 5.6 %

The stock has a 50-day simple moving average of $1.23 and a 200 day simple moving average of $1.25. The company has a market cap of $10.72 million, a price-to-earnings ratio of -0.56 and a beta of 2.13.

Imunon (NASDAQ:IMNN) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.51) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.55) by $0.04. As a group, research analysts forecast that Imunon, Inc. will post -1.71 EPS for the current fiscal year.

About Imunon

Imunon, Inc, a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development.